MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
September 08, 2024 19:10 ET | MacroGenics, Inc.
ROCKVILLE, MD, Sept. 08, 2024 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative...
DMR Logo.png
Antibody Drug Conjugates Market Is Expected To Reach Revenue Of USD 51.2 Bn By 2033, at 15.8% CAGR: Dimension Market Research
September 05, 2024 11:45 ET | Dimension Market Research
New York, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Overview The Global Antibody Drug Conjugates (ADCs) Market is projected to grow from USD 13.7 billion in 2024 to USD 51.2 billion by 2033, at a CAGR...
Global Regenerative Medicine Market
Regenerative Medicine Market Report 2024 - Industry Dynamics, Opportunity Analysis, and Regional Growth Forecasts to 2031
September 02, 2024 09:57 ET | Research and Markets
Dublin, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market by Product Type, Material, Application, End User and Region - Market Size, Industry Dynamics, Opportunity Analysis and...
Immunology Market to Reach $204.0 Billion, Globally, by 2033 at 6.3% CAGR: Allied Market Research
August 28, 2024 06:40 ET | Allied Analytics LLP
Wilmington, Delaware, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Immunology Market by Product Type (Diagnostic Testing Equipment, Biomarkers and...
22157.jpg
Peptide Therapeutics Market Forecast to 2028: Projected to Grow by $17.85 Billion, Driven by a Strong Pipeline and Favorable Reimbursement Policies
August 26, 2024 07:56 ET | Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The peptide therapeutics market is forecasted...
Global Biopharmaceuticals Market
Biopharmaceuticals Global Business Report 2024 with Focus on 200+ Select Players Including Abbott, Amgen, Biogen, Eli Lilly and Co, F. Hoffmann-La Roche, J&J, Merck, Novo Nordisk, Pfizer, Sanofi
August 23, 2024 07:20 ET | Research and Markets
Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
2024 Microbiome Market Trend
2024 Microbiome Market Trends Report: Competitive Environment Analysis, Digital Platform and Marketing Strategies, and AI Adoption in the Industry
August 22, 2024 10:56 ET | Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "2024 Microbiome Market Trend" report has been added to ResearchAndMarkets.com's offering. In the microbiome therapeutics market, some microbiome...
Global Human Microbiome Market
Human Microbiome Market Projected to Surpass to $3 Billion by 2032 with DuPont, Evelo Bio, Finch Therapeutics, Ginkgo Bioworks, Seres Therapeutics, AOBiome, Astarte Medical, Axial Biotherapeutics
August 14, 2024 09:02 ET | Research and Markets
Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Human Microbiome Market Report by Application Disease Product, Countries and Company Analysis, 2024-2032" report has been added to ...
22157.jpg
Agile Leadership for Pharma and Biopharma Professionals in a Hybrid World: 2-Day Training Course (Online) November 18-19, 2024 - Become Competent and Familiar in a Range of Well-Recognised Leadership Techniques
August 07, 2024 04:22 ET | Research and Markets
Dublin, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "Agile Leadership for Pharma and Biopharma Professionals in a hybrid world Training Course" conference has been added to ResearchAndMarkets.com's...
22157.jpg
Risk Management for Pharma and Biopharma Professionals: 1-Day Online Training Course (October 8, 2024) - Identify, Evaluate and Implement Specific Risk-based Techniques for Risk Management
August 06, 2024 06:43 ET | Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Risk Management for Pharma and Biopharma Professionals Training Course" conference has been added to ResearchAndMarkets.com's offering. Risk...